Delaware
|
1-11388
|
04-3153858
|
||
(State or other jurisdiction of
incorporation)
|
(Commission File Number)
|
(I.R.S. Employer
Identification No.)
|
345 Inverness Drive South, Building B, Suite 250
Englewood, Colorado
|
80112
|
|
(Address of principal executive offices)
|
(Zip Code)
|
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
Trading symbol(s)
|
Name of each exchange on which registered
|
Common Stock
|
VIVE
|
Nasdaq Capital Market
|
VIVEVE MEDICAL, INC.
|
|||
By:
|
/s/ Scott Durbin
|
||
Name:
|
Scott Durbin
|
||
Title:
|
Chief Executive Officer
|
Date:
|
November 23, 2022
|